Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-28 @ 12:01 AM
Study NCT ID:
NCT04515394
Status:
TERMINATED
Last Update Posted:
2022-12-22
First Post:
2020-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
Sponsor:
EMD Serono Research & Development Institute, Inc.